HARROW, INC. — Director's Dealing 2015

May 16, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2015-05-13

Reporting Person: Kammer Robert J (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-13	Common Stock	A	6281	—	Acquired	994827	Direct

Footnotes

F1: Award of Restricted Stock Units vests quarterly in equal installments over a one year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.

F2: The Restricted Stock Units were received as a compensatory award for no consideration.